| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104172A1 Preventive and/or therapeutic agent for rheumatoid arthritis |
| 10/05/2006 | WO2006104161A1 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-Met AUTOPHOSPHORYLATION INHIBITING POTENCY |
| 10/05/2006 | WO2006104154A1 Composition for enhancing expression and activity of protease in liver |
| 10/05/2006 | WO2006104153A1 Composition for increasing anti-oxidation activity in blood |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006104137A1 Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006104086A1 Therapeutic agent for thrombosis |
| 10/05/2006 | WO2006104030A1 Thiazole compound |
| 10/05/2006 | WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | WO2006103999A1 Novel carbapenem compound |
| 10/05/2006 | WO2006103939A1 Whitening agent or pigmentation improving agent based on antioxidative action of neohesperidin |
| 10/05/2006 | WO2006103691A1 Stable pharmaceutical compositions of platinum (ii) antitumour agents |
| 10/05/2006 | WO2006103690A1 A novel process for preparation of substantially pure glimepiride |
| 10/05/2006 | WO2006103688A1 A novel crystalline form of rupatadine free base |
| 10/05/2006 | WO2006103568A2 NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF |
| 10/05/2006 | WO2006103562A2 Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment |
| 10/05/2006 | WO2006103559A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 10/05/2006 | WO2006103555A1 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 10/05/2006 | WO2006103551A1 Controlled release formulations of oxycodone |
| 10/05/2006 | WO2006103546A2 Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands |
| 10/05/2006 | WO2006103545A1 4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 10/05/2006 | WO2006103544A2 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 10/05/2006 | WO2006103527A1 Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/05/2006 | WO2006103506A1 Sertraline-containing pharmaceutical compositions and a process for preparation thereof |
| 10/05/2006 | WO2006103503A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 10/05/2006 | WO2006103463A1 Iron modulators |
| 10/05/2006 | WO2006103417A1 New pharmaceutical compositions useful in the treatment of parkinson's disease |
| 10/05/2006 | WO2006103407A2 New pharmaceutical compositions useful in the treatment of migraine |
| 10/05/2006 | WO2006103399A1 Hiv integrase inhibitors |
| 10/05/2006 | WO2006103345A1 Tyrosinase inhibitors and their use for treating hyperpigmentary disorders |
| 10/05/2006 | WO2006103342A2 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 10/05/2006 | WO2006103277A2 2 , 4 , 5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103275A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103273A1 Substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103261A2 Inhibitors of neurotrypsin and determination thereof |
| 10/05/2006 | WO2006103255A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | WO2006103206A2 Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 10/05/2006 | WO2006103187A2 Method for administration of capecitabine |
| 10/05/2006 | WO2006103088A1 Novel hydroxyethylamine and ketone compounds having asp2 inhibitory activity |
| 10/05/2006 | WO2006103056A2 Topical product containing betaine for preventing and treating nappy rash |
| 10/05/2006 | WO2006103011A1 Pharmaceutical preparation of n -[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide |
| 10/05/2006 | WO2006103010A1 Cyclic iminopeptide derivatives |
| 10/05/2006 | WO2006102998A1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine |
| 10/05/2006 | WO2006102958A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 10/05/2006 | WO2006102900A1 Dermatological compositions and salts for the treatment of dermatological diseases |
| 10/05/2006 | WO2006102899A2 Oxaprozin or closely related compound for the treatment and prevention of |
| 10/05/2006 | WO2006102898A2 Oxaprozin or a closely related compound for the treatment of eczema |
| 10/05/2006 | WO2006102854A1 A conjugate of biomacromolecule with bioreductive and preparative method thereof |
| 10/05/2006 | WO2006102804A1 The compound preparation for treating diabetes mellitus |
| 10/05/2006 | WO2006102789A1 Ferula fukanensis extract, the preperation method and the use in producing medicine thereof |
| 10/05/2006 | WO2006102788A1 The complex antihyperlipidemics |
| 10/05/2006 | WO2006102768A1 Colloidal solid lipid vehicle for pharmaceutical use |
| 10/05/2006 | WO2006102766A1 Garlic extract and chitosan compositions, and uses thereof |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006102759A1 Novel substituted 2-nitroimidazoles useful for hypoxic cell therapy and imaging |
| 10/05/2006 | WO2006102758A1 Preparation of taxanes from 9-dihydro-13-acetylbaccatin iii |
| 10/05/2006 | WO2006102752A1 Compositions for oral transmucosal delivery of metformin |
| 10/05/2006 | WO2006102750A1 Combined-step process for pharmaceutical compositions |
| 10/05/2006 | WO2006102748A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 10/05/2006 | WO2006102728A2 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 10/05/2006 | WO2006102717A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
| 10/05/2006 | WO2006091972A3 Dimeric iap inhibitors |
| 10/05/2006 | WO2006091800A3 Novel pyridine derivatives as potassium ion channel openers |
| 10/05/2006 | WO2006090273A3 [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia |
| 10/05/2006 | WO2006086648A3 Treatment for topical use alleviating or inhibiting joint pain or muscle pain or musculoskeletal pain in a mammal |
| 10/05/2006 | WO2006085932A3 Anti-viral uses of borinic acid complexes |
| 10/05/2006 | WO2006085335A3 Pharmaceutical composition of acid labile substances |
| 10/05/2006 | WO2006085168A3 Solid oral dosage forms of ziprasidone containing colloidal silicone dioxide |
| 10/05/2006 | WO2006079910A3 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity |
| 10/05/2006 | WO2006078576A3 Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 10/05/2006 | WO2006077387A3 Novel benzamide derivatives |
| 10/05/2006 | WO2006076595A8 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 10/05/2006 | WO2006075084A3 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 10/05/2006 | WO2006074799A3 5-pyrrolidinylsulfonyl isatin derivatives |
| 10/05/2006 | WO2006073835A3 Regiments for intra-articular viscosupplementation |
| 10/05/2006 | WO2006072809A8 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions |
| 10/05/2006 | WO2006072458A3 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 10/05/2006 | WO2006071844A3 Oxygen-impervious packaging and methods for storing thyroid hormone |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 10/05/2006 | WO2006071138A8 Tritium-traced saxitoxin dihydrochloride and method for the production thereof |
| 10/05/2006 | WO2006069097A3 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 10/05/2006 | WO2006068826A3 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| 10/05/2006 | WO2006064249A3 Process for the preparation of pantoprazole sodium |
| 10/05/2006 | WO2006062716A3 Methods and compositions for treating ocular disorders |
| 10/05/2006 | WO2006060809A3 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 10/05/2006 | WO2006059247A3 VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
| 10/05/2006 | WO2006058073A3 Pharmaceutical compositions comprising a selective cox-2 inhibitor and a diuretic |
| 10/05/2006 | WO2006058012A3 Gonadotropin releasing hormone receptor antagonists |
| 10/05/2006 | WO2006057914A3 2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol |
| 10/05/2006 | WO2006057884A3 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 10/05/2006 | WO2006055747A3 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 10/05/2006 | WO2006055511A3 Stable tablet formulation of tetrahydrobiopterin |
| 10/05/2006 | WO2006053012A3 Novel pharmaceutical compositions for treating acquired chronic pain and associated dysphoria |
| 10/05/2006 | WO2006050511A3 Butyrophenomenes and sigma-1 receptor antagonists protect against oxidatives-stress |
| 10/05/2006 | WO2006048330A8 11βετα-hsd1 inhibitors |
| 10/05/2006 | WO2006048248A3 Novel anthranilamide pyridinureas as vegf receptor kinase imhibitors |
| 10/05/2006 | WO2006047196A3 Cgrp receptor antagonists |